Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Diabetes Technology & Therapeutics
|
November 27, 2002
Technosphere/Insulin--a new approach for effective delivery of human insulin via the pulmonary route
Andreas Pfützner, Alfred E Mann, Solomon S Steiner
Journal of Diabetes Science and Technology
|
December 7, 2010
Stabilized glucagon formulation for bihormonal pump use
Solomon S Steiner, Ming Li, Robert Hauser, et al.
Thrombosis Research
|
July 30, 2016
Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin
Jack E Ansell, Bryan E Laulicht, Sasha H Bakhru, et al.
Journal of Diabetes Science and Technology
|
November 4, 2009
Intra-individual variability of the metabolic effect of a novel rapid-acting insulin (VIAject) in comparison to regular human insulin
Marcus Hompesch, Laura McManus, Roderike Pohl, et al.
The New England Journal of Medicine
|
November 6, 2014
Use of PER977 to reverse the anticoagulant effect of edoxaban
Jack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Thrombosis and Haemostasis
|
November 18, 2016
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban
Jack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Diabetes Technology & Therapeutics
|
November 27, 2002
Technosphere/Insulin--a new approach for effective delivery of human insulin via the pulmonary route
Andreas Pfützner, Alfred E Mann, Solomon S Steiner
Journal of Diabetes Science and Technology
|
December 7, 2010
Stabilized glucagon formulation for bihormonal pump use
Solomon S Steiner, Ming Li, Robert Hauser, et al.
Thrombosis Research
|
July 30, 2016
Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin
Jack E Ansell, Bryan E Laulicht, Sasha H Bakhru, et al.
Journal of Diabetes Science and Technology
|
November 4, 2009
Intra-individual variability of the metabolic effect of a novel rapid-acting insulin (VIAject) in comparison to regular human insulin
Marcus Hompesch, Laura McManus, Roderike Pohl, et al.
The New England Journal of Medicine
|
November 6, 2014
Use of PER977 to reverse the anticoagulant effect of edoxaban
Jack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Thrombosis and Haemostasis
|
November 18, 2016
Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban
Jack E Ansell, Sasha H Bakhru, Bryan E Laulicht, et al.
Page
of 1